Does bupropion extended-release (XL) 300 mg require a taper when discontinuing?

Bupropion XL 300mg Discontinuation

Yes, bupropion XL 300 mg requires a taper when discontinuing. The FDA-approved prescribing information explicitly states: "When discontinuing treatment in patients treated with bupropion hydrochloride extended-release tablets (XL) 300 mg once daily, decrease the dose to 150 mg once daily prior to discontinuation" 1.

Recommended Tapering Protocol

For patients on 300 mg daily:

• Reduce to 150 mg once daily
• Continue at 150 mg for a period before complete discontinuation
• Then stop

The FDA label does not specify the exact duration to remain at 150 mg before stopping, but based on general principles of minimizing withdrawal and the drug's mechanism of action as a dopamine/norepinephrine reuptake inhibitor, maintaining the 150 mg dose for at least 1-2 weeks is reasonable clinical practice.

Why Tapering Matters

While bupropion is not associated with the classic antidepressant discontinuation syndrome seen with SSRIs or SNRIs, abrupt discontinuation can still cause problems:

• Neuropsychiatric effects: The NCCN guidelines note that providers should monitor for development or worsening of serious neuropsychiatric issues including depression and suicidal ideation when using bupropion 2
• Seizure risk considerations: Bupropion lowers the seizure threshold, and gradual dose reduction allows for safer discontinuation 1
• Return of underlying symptoms: Whether used for depression or smoking cessation, tapering allows monitoring for symptom recurrence versus withdrawal effects

Clinical Context by Indication

For Major Depressive Disorder:

• The FDA label recommends tapering from 300 mg to 150 mg before stopping 1
• This applies whether used for acute treatment or maintenance therapy
• Periodically reassess the need for continued treatment

For Seasonal Affective Disorder:

• The same taper applies: reduce from 300 mg to 150 mg before discontinuation 1
• Timing: taper and discontinue in early spring
• The gradual reduction helps distinguish withdrawal from seasonal symptom patterns

For Smoking Cessation:

• Standard dosing reaches maximum 300 mg per day (150 mg twice daily) 2
• While the smoking cessation guidelines don't explicitly detail discontinuation protocols, the same FDA-mandated taper principle applies
• Duration: 7-12 weeks of treatment, with therapy potentially extended to 6 months-1 year 2

Special Populations Requiring Extra Caution

Hepatic impairment:

• Moderate to severe (Child-Pugh 7-15): maximum dose is 150 mg every other day
• If discontinuing from this dose, consider even more gradual reduction 1

Renal impairment:

• GFR <90 mL/min: consider reducing dose and/or frequency
• Tapering should be proportionally slower 1

Patients on combination therapy:

• When used with naltrexone (Contrave): the bupropion component still requires tapering 3, 4
• When combined with NRT for smoking cessation: taper bupropion as directed while managing nicotine replacement separately 2

Common Pitfall to Avoid

Do not abruptly stop bupropion XL 300 mg. The explicit FDA guidance exists because abrupt discontinuation increases risk of:

• Neuropsychiatric adverse events
• Seizure risk (though rare at therapeutic doses)
• Difficulty distinguishing withdrawal from relapse of underlying condition

The taper from 300 mg to 150 mg is not optional—it is part of the FDA-approved dosing instructions and should be followed for all patients unless contraindicated by specific clinical circumstances requiring immediate cessation.